flegmonan

Flegmonan is a term used in some medical contexts to denote a phlegmon, a diffuse, suppurative inflammation of soft tissue that spreads through interstitial spaces. Unlike a localized abscess with a discrete cavity, early phlegmonous inflammation lacks a clearly defined abscess but can progress to abscess formation or further tissue involvement. The term appears in various languages as a variant of phlegmon or as a regional designation for phlegmonous infection.

Causes of flegmonan typically involve bacterial infections, most commonly streptococci and staphylococci, but anaerobic bacteria and mixed flora may be involved as well. Infections can originate from skin or soft tissue trauma, dental or orofacial infections, abdominal or pelvic infections, or perineal sources. Risk factors include diabetes, vascular disease, immunosuppression, and delayed treatment.

Pathophysiology involves an inflammatory response with edema and neutrophilic infiltration that disseminates through connective tissues and fascial planes. This can cause extensive swelling, tenderness, and redness and may lead to tissue necrosis if not controlled. Complications include progression to abscess, sepsis, or spread to adjacent compartments.

Clinical features typically include evolving swelling, warmth, tenderness, and fever, with general signs of systemic illness in more extensive disease. Diagnosis relies on clinical examination supported by laboratory tests showing leukocytosis and elevated inflammatory markers, and imaging such as ultrasound or CT to assess extent and identify collections. Cultures from drainage or aspirates help tailor antibiotics.

Treatment centers on prompt antimicrobial therapy and source control. Empiric broad-spectrum antibiotics are adjusted based on cultures, with surgical drainage or debridement when abscess or necrotic tissue is present. Prognosis improves with early recognition and appropriate management.

See also: phlegmon, cellulitis, abscess.